Maxbon™ is a bisphosphonate medication containing Ibandronic Acid 150 mg, manufactured by Square Pharmaceuticals Ltd., Bangladesh. It is primarily used for the treatment and prevention of osteoporosis in postmenopausal women and men, aiming to increase bone mineral density and reduce the risk of fractures